Corticosteroid Sparing Effects of Treatment With Guselkumab in Patients With Moderate to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results Through Week 44

被引：0

作者：

Bressler, Brian ^{[1
]}

Allegretti, Jessica R. ^{[2
]}

Rubin, David T. ^{[3
]}

Shipitofsky, Nicole ^{[4
]}

Huang, Kuan-Hsiang G. ^{[4
]}

Germinaro, Matthew ^{[4
]}

Wilson, Rebbecca ^{[5
]}

Zhang, Hongyan ^{[4
]}

Armuzzi, Alessandro ^{[6
]}

Fishman, Sigal ^{[7
]}

Wang, Yufang ^{[8
]}

Panes, Julian ^{[9
]}

Lichtenstein, Gary R. ^{[10
]}

Peyrin-Biroulet, Laurent ^{[11
,12
]}

机构：

[1] Univ British Columbia, IBD Ctr BC, Vancouver, BC, Canada

[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA

[3] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA

[4] Janssen Res & Dev, Spring House, PA USA

[5] Janssen Res & Dev LLC, Spring House, PA USA

[6] IRCCS Humanitas Res Hosp, Milan, Italy

[7] Sourasky Med Ctr, Tel Aviv, Israel

[8] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[9] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Barcelona, Catalonia, Spain

[10] Univ Penn, Perelman Ctr Adv Med, Philadelphia, PA USA

[11] Nancy Univ Hosp, INFINY Inst, FHU CURE, INSERM NGERE, Vandoeuvre Les Nancy, Lorraine, France

[12] McGill Univ Hlth Ctr, Montreal, PQ, Canada

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001034976.21441.52

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1402

引用

页码：S1002 / S1002

页数：1

共 50 条

[1] The Efficacy of Maintenance Treatment with Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results at Week 44 by Biologic/Janus Kinase History
Allegretti, Jessica R.
Panes, Julian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Zhan, Jia
Zhang, Hongyan
Begun, Jakob
Kierkus, Jaroslaw
Kravchenko, Tetiana
Hisamatsu, Tadakazu
Rubin, David T.
Bressler, Brian
Dignass, Axel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S882 - S882
[2] Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Week 44 Results From the Phase 3 QUASAR Maintenance Study
Panes, Julian
Dignass, Axel
Hisamatsu, Tadakazu
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Sridhar, Sunandini
Branigan, Patrick
Wilson, Rebbecca
Zhang, Hongyan
Magro, Fernando
Jairath, Vipul
Feagan, Brian G.
Lichtenstein, Gary R.
Rubin, David T.
Sands, Bruce E.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1041 - S1041
[3] Corticosteroid sparing effects of treatment with guselkumab in patients with moderate to severely active Crohn's disease: Phase 3 GALAXI 2/3 results through week 48
Panes, J.
Hisamatsu, T.
Armuzzi, A.
Terry, N. A.
Salese, L.
Van Rampelbergh, R.
Yee, J.
Wan, K. Y.
Yang, Z.
Pin, S.
Sands, B. E.
Rubin, D. T.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1724 - i1725
[4] THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY
Rubin, David T.
Allegretti, Jessica R.
Panes, Julian
Shipitofsky, Nicole
Yarandi, Shadi
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Wilson, Rebbecca
Zhang, Hongyan
Feagan, Brian G.
Hisamatsu, Tadakazu
Lichtenstein, Gary R.
Bressler, Brian
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Dignass, Axel
GASTROENTEROLOGY, 2024, 166 (05) : S180 - S180
[5] Corticosteroid sparing effects of treatment with guselkumab in patients with moderately to severely active Crohn's disease: Phase 3 GRAVITI study results through week 48
Hart, A.
Panaccione, R.
Steinwurz, F.
Cao, Q.
Hisamatsu, T.
Nancey, S.
Olurinde, M.
Yang, Z.
Merrall, E.
Terry, N. A.
Sands, B. E.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1662 - i1663
[6] Cumulative response to guselkumab through week 24 of induction in patients with moderately to severely active ulcerative colitis: Results from the phase 3 QUASAR induction study
Rubin, D.
Sands, B.
Lichtenstein, G.
Baker, T.
Huang, K. H.
Germinaro, M.
Miao, Y.
Zhang, H.
Nancey, S.
Allegretti, J.
Feagan, B.
Hisamatsu, T.
Panes, J.
Dignass, A.
Bressler, B.
Peyrin-Biroulet, L.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1722 - I1723
[7] Cumulative Response to Guselkumab Through Week 24 of Induction in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
Rubin, David T.
Sands, Bruce E.
Lichtenstein, Gary R.
Baker, Thomas
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Miao, Ye
Zhang, Hongyan
Nancey, Stephane
Allegretti, Jessica R.
Feagan, Brian G.
Hisamatsu, Tadakazu
Panes, Julian
Dignass, Axel
Bressler, Brian
Peyrin-Biroulet, Laurent
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S672 - S673
[8] GUSELKUMAB IMPROVES SYMPTOMS OF FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12
Dignass, Axel
Panes, Julian
Rubin, David T.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Pandya, Dwiti
Han, Chenglong
Miao, Ye
Zhang, Hongyan
Gu, Fang
Rowbotham, David S.
Mihaly, Emese
Bressler, Brian
Lichtenstein, Gary R.
Allegretti, Jessica R.
GASTROENTEROLOGY, 2024, 166 (05) : S848 - S849
[9] Guselkumab improves symptoms of fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study results at Week 12
Dignass, A.
Panes, J.
Rubin, D. T.
Huang, K. H. G.
Germinaro, M.
Pandya, D.
Han, C.
Miao, Y.
Zhang, H.
Gu, F.
Rowbotham, D.
Mihaly, E.
Bressler, B.
Lichtenstein, G. R.
Allegretti, J. R.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I165 - I166
[10] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 213 QUASAR STUDY RESULTS THROUGH WEEK 12
Allegretti, Jessica R.
Rubin, David T.
Bressler, Brian
Huang, Kuan-Hsiang G.
Shipitofsky, Nicole
Germinaro, Matthew
Zhang, Hongyan
Johanns, Jewel
Feagan, Brian
Sandborn, William J.
Sands, Bruce E.
Hisamatsu, Tadakazu
Lichi, Gary R.
Lichtenstein, Gary R.
Panes, Julian
Dignass, Axel
GASTROENTEROLOGY, 2022, 162 (07) : S963 - S964

← 1 2 3 4 5 →